ATL001 in Patients With Metastatic or Recurrent Melanoma
Clinical trial NCT03997474 · TERMINATED
Trial details
- NCT number
- NCT03997474
- Sponsor
- Achilles Therapeutics UK Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-15
- Primary completion
- 2024-09-03
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.